Nuversys is a cutting-edge Food-Tech startup with a proprietary Technology of Microencapsulation Delivery system. Founded in 2019 and headquartered in Israel, Nuversys has secured a $2.50M investment in a Seed Round from Feat Investments on 01 January 2000. Nuversys™' innovative patented solution for INBODY NUTRIENTS DELIVERY is the ONLY ONE IN THE WORLD micro-encapsulation technology that offers several key advantages. Their patented “N-Pearls" Platform allows for superior nutrient retention, protection during food processing, and controlled release in the digestive tract, enhancing nutrient absorption and minimizing side-effects. Additionally, Nuversys' N-Pearl products are characterized by their unique features, including non-disintegration in water or oil, compatibility with various food applications, flawless dispersion, and compliance with vegan and parve kosher restrictions. This disruptive technology positions Nuversys at the forefront of the Food and Beverage, Health Care, and Nutrition industries, with the potential to revolutionize the way nutrients are delivered and consumed. With its innovative approach and strong investor backing, Nuversys presents an enticing opportunity for venture capital firms seeking to invest in groundbreaking Food-Tech solutions.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Seed Round | $2.50M | 1 | Feat Investments | 01 Jan 2000 |
No recent news or press coverage available for Nuversys.